Global MAD Oral Device Market Size By Type (One Piece Device, Two Piece Devices), By Application (Mild to Moderate OSA, Severe OSA), By Region, And Segment Forecasts, 2023 to 2032

The Global MAD (Mandibular Advancement Device) Oral Device Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 4.5 billion by 2031, growing at a CAGR of 9.8% during the forecast period of 2023 to 2031. The market's expansion is driven by the rising prevalence of obstructive sleep apnea (OSA), increasing awareness about sleep-related disorders, and the growing preference for non-invasive treatments over surgical interventions. MADs are effective in repositioning the lower jaw to prevent airway obstruction during sleep, making them a popular choice among OSA patients.

Drivers:

1. Rising Incidence of Obstructive Sleep Apnea (OSA):

OSA affects millions globally, particularly among aging and obese populations. The rising diagnosis rates and awareness campaigns around sleep health have significantly contributed to the increased demand for oral appliances like MADs.

2. Growing Preference for Non-Invasive Treatment:

Compared to CPAP machines or surgical procedures, MADs are less invasive, more comfortable, and easier to use. This shift in patient preference is fueling their adoption, especially in mild-to-moderate OSA cases.

3. Technological Advancements and Customization:

Innovation in materials, 3D scanning, and digital impressions have led to the creation of more effective, custom-fit MADs. This improves comfort and efficacy, thereby enhancing patient compliance.

Restraints:

1. Limited Effectiveness for Severe OSA Cases:

While effective for mild-to-moderate OSA, MADs are not always suitable for patients with severe apnea or complex anatomical conditions, limiting their overall market scope.

2. Variability in Reimbursement Policies:

Inconsistent insurance coverage and reimbursement policies across different regions can hinder access and adoption, especially in low-income areas.

Opportunity:

1. Expansion in Emerging Markets:

Countries in Asia-Pacific and Latin America are witnessing rising healthcare expenditure and awareness, presenting untapped potential for MAD oral devices.

2. Integration with Digital Health Technologies:

The incorporation of smart sensors and remote monitoring capabilities into MADs can provide real-time data on treatment efficacy, creating a new frontier in personalized sleep medicine.

Market by System Type Insights:

In 2023, the Custom-Fit Devices segment accounted for the largest market share due to their superior comfort and efficacy. These devices are crafted based on a patient’s dental impressions and are often preferred by clinicians for long-term use. However, the Boil-and-Bite Devices segment is expected to witness the highest growth rate owing to their affordability and convenience, particularly in retail and OTC channels.

Market by End-use Insights:

The Sleep Clinics segment dominated the market in 2023, driven by the professional diagnosis and fitting services provided in clinical settings. Meanwhile, the Homecare Settings segment is expected to grow significantly during the forecast period, supported by rising direct-to-consumer sales, telehealth consultations, and increased awareness of sleep health among individuals.

Market by Regional Insights:

North America led the MAD oral device market in 2023, attributed to its advanced healthcare infrastructure, high awareness levels, and favorable reimbursement landscape. However, Asia-Pacific is anticipated to experience the highest CAGR during the forecast period, driven by rapid urbanization, increasing obesity rates, and expanding access to healthcare services in countries like China and India.

Competitive Scenario:

Key players in the Global MAD Oral Device Market include SomnoMed Ltd., ProSomnus Sleep Technologies, ResMed Inc., Apnea Sciences Corporation, DynaFlex, OravanOSA, Panthera Dental, and Vivos Therapeutics, Inc. These companies are investing in R&D, partnerships with dental clinics, and expanding their product offerings to cater to both clinical and consumer markets.

Key Market Developments:

In 2023, ProSomnus launched a digitally-enabled oral device integrated with remote monitoring sensors for sleep tracking.

SomnoMed expanded its clinical footprint in Europe through strategic partnerships with leading sleep centers in 2024.

Vivos Therapeutics secured FDA approval for a next-generation MAD targeting patients with moderate OSA in 2025.

Scope of Work – Global MAD Oral Device Market

Report Metric Details

Market Size (2023) USD 2.1 Billion

Projected Market Size (2031) USD 4.5 Billion

CAGR (2023–2031) 9.8%

Market Segments System Type (Custom-Fit, Boil-and-Bite), End-use (Sleep Clinics, Homecare Settings), Region

Growth Drivers Rising prevalence of sleep apnea, preference for non-invasive treatments, technological innovation

Opportunities Emerging markets, digital integration of MADs

FAQs:

1) What is the current market size of